Department of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Global Center of Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia, Family Medicine, Primary Health Center, Riyadh, Saudi Arabia.
J Infect Public Health. 2022 May;15(5):526-532. doi: 10.1016/j.jiph.2022.03.013. Epub 2022 Mar 25.
Many survivors of COVID-19 have developed symptoms and diseases similar to those observed after severe acute respiratory syndrome (SARS). Therefore, this study aimed to characterize the symptoms that appear after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been eradicated and to determine their relationship with COVID-19 severity.
This multicenter, retrospective cross-sectional study was conducted in all eligible confirmed cases of SARS-CoV-2 infection from Saudi Arabia. Study participants were randomly selected using computerized random sampling from a population of 314,821 patients. Descriptive statistics were used to describe baseline demographic data and clinical characteristics. Categorical variables were presented as counts and percentages, while continuous variables were presented as means and standard deviations.
Approximately 70% of patients were found to have five or fewer symptoms simultaneously. Late symptoms (in the ongoing symptomatic COVID-19) occurred in 225 (22·5%) patients with the most common late symptoms being loss of smell, loss of taste, fatigue, shortness of breath, and cough (52·4%, 31·1%, 11·5%, 10·2%, and 8·9% of patients with late symptoms, respectively). We also found that the presence of acute symptoms of COVID-19 and admission to the hospital were significant independent predictors of the post-COVID-19 condition.
Saudi patients with COVID-19 develop a wide range of symptoms, similar to those observed and reported in other countries. The loss of smell, the loss of taste, shortness of breath, and fatigue were the main persistent symptoms. Regular follow-up of COVID-19 survivors is highly recommended to minimize the burden of the post-acute COVID-19 condition and improve the quality of life of patients.
许多 COVID-19 幸存者出现了类似于严重急性呼吸综合征(SARS)后观察到的症状和疾病。因此,本研究旨在描述消除严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染后出现的症状,并确定它们与 COVID-19 严重程度的关系。
这是一项多中心、回顾性、横断面研究,在沙特阿拉伯所有符合条件的 SARS-CoV-2 感染确诊病例中进行。研究参与者使用计算机随机抽样从 314821 名患者中随机选择。使用描述性统计数据描述基线人口统计学数据和临床特征。分类变量以计数和百分比表示,连续变量以平均值和标准差表示。
约 70%的患者同时存在 5 种或更少的症状。晚期症状(在持续有症状的 COVID-19 中)发生在 225 名(22.5%)患者中,最常见的晚期症状是嗅觉丧失、味觉丧失、疲劳、呼吸急促和咳嗽(52.4%、31.1%、11.5%、10.2%和 8.9%的有晚期症状的患者)。我们还发现,COVID-19 的急性症状存在和住院是 COVID-19 后状况的显著独立预测因素。
沙特 COVID-19 患者出现了广泛的症状,与其他国家观察到和报告的症状相似。嗅觉丧失、味觉丧失、呼吸急促和疲劳是主要的持续性症状。强烈建议对 COVID-19 幸存者进行定期随访,以最大限度地减少 COVID-19 后状况的负担并提高患者的生活质量。